Insider filing · MPLT
Robert C. Malenka
Director
profile →
MapLight Therapeutics, Inc.
MPLT · Healthcare · 30 filings in 24 months
ticker →
Robert C. Malenka sold $623K of MapLight Therapeutics (MPLT)
Executed Jan 28, disclosed Jan 30, 2 days later.
Value, as filed
$623K
33,734 sh across 3 lots
Executed
Jan 28
the trade date, as filed
Disclosed
Jan 30
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RMRobert C. Malenka (Director) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in MapLight Therapeutics, Inc. (MPLT). The largest single filing was $623K of MPLT (33,734 sh across 3 lots, as filed), executed Jan 28.
The name
MPLTHealthcare · MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Robert C. Malenka in MPLT
MPLTSALE
MapLight Therapeutics, Inc.
$231K8,593 sh × $26.90
Exec Apr 15
Filed Apr 17 · 5:30 PM ET MPLTSALE MapLight Therapeutics, Inc. $198K
10,788 sh × $18.39
Exec Feb 23
Filed Feb 24 · 5:30 PM ET MPLTSALE MapLight Therapeutics, Inc. $221K
12,116 sh × $18.21
Exec Feb 13
Filed Feb 18 · 5:30 PM ET MPLTSALE MapLight Therapeutics, Inc. $120K
6,622 sh × $18.12
Exec Feb 10
Filed Feb 12 · 5:30 PM ET MPLTSALE MapLight Therapeutics, Inc. $127K
7,039 sh × $18.02
Exec Feb 2
Filed Feb 4 · 5:30 PM ET